Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Weimar

Showing results (121-130 of 173) with videos related to

Pageof 18
Sort By:
European Heart Journal|July 5, 2015
Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysisDavid M Kent, Issa J Dahabreh, Robin Ruthazer, et al.
The Lancet. Neurology|June 16, 2016
Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trialThorsten Steiner, Sven Poli, Martin Griebe, et al.
European Stroke Journal|April 3, 2024
Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST studyHans-Christoph Diener, Gerrit M Grosse, Anika Hüsing, et al.
European Heart Journal|July 27, 2014
Progression of coronary artery calcification seems to be inevitable, but predictable - results of the Heinz Nixdorf Recall (HNR) studyRaimund Erbel, Nils Lehmann, Sofia Churzidse, et al.
Deutsches Arzteblatt International|May 7, 2026
The Course of Rehabilitation of Ventilated and Tracheally Cannulated Patients in Neurological-Neurosurgical Early RehabilitationTobias Schmidt-Wilcke, Frederick Benjamin Junker, Andreas Bender, et al.
Neurology|October 24, 2014
Determinants of antithrombotic choice for patent foramen ovale in cryptogenic strokeDavid E Thaler, Robin Ruthazer, Christian Weimar, et al.
Circulation. Cardiovascular Imaging|November 12, 2013
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism databaseBenjamin S Wessler, David E Thaler, Robin Ruthazer, et al.
Neurology|July 21, 2017
Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillationEleni Korompoki, Filippos T Filippidis, Peter B Nielsen, et al.
Stroke|October 17, 2009
Recombinant human erythropoietin in the treatment of acute ischemic strokeHannelore Ehrenreich, Karin Weissenborn, Hilmar Prange, et al.
Circulation. Cardiovascular Imaging|May 22, 2014
Response to letter regarding article, "Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale analysis of putative high-risk features from the risk of paradoxical embolism database"Benjamin S Wessler, David E Thaler, Robin Ruthazer, et al.
Pageof 18

Showing results (121-130 of 173) with videos related to

Sort By:
Pageof 18
European Heart Journal|July 5, 2015
Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysisDavid M Kent, Issa J Dahabreh, Robin Ruthazer, et al.
The Lancet. Neurology|June 16, 2016
Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trialThorsten Steiner, Sven Poli, Martin Griebe, et al.
European Stroke Journal|April 3, 2024
Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST studyHans-Christoph Diener, Gerrit M Grosse, Anika Hüsing, et al.
European Heart Journal|July 27, 2014
Progression of coronary artery calcification seems to be inevitable, but predictable - results of the Heinz Nixdorf Recall (HNR) studyRaimund Erbel, Nils Lehmann, Sofia Churzidse, et al.
Deutsches Arzteblatt International|May 7, 2026
The Course of Rehabilitation of Ventilated and Tracheally Cannulated Patients in Neurological-Neurosurgical Early RehabilitationTobias Schmidt-Wilcke, Frederick Benjamin Junker, Andreas Bender, et al.
Neurology|October 24, 2014
Determinants of antithrombotic choice for patent foramen ovale in cryptogenic strokeDavid E Thaler, Robin Ruthazer, Christian Weimar, et al.
Circulation. Cardiovascular Imaging|November 12, 2013
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism databaseBenjamin S Wessler, David E Thaler, Robin Ruthazer, et al.
Neurology|July 21, 2017
Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillationEleni Korompoki, Filippos T Filippidis, Peter B Nielsen, et al.
Stroke|October 17, 2009
Recombinant human erythropoietin in the treatment of acute ischemic strokeHannelore Ehrenreich, Karin Weissenborn, Hilmar Prange, et al.
Circulation. Cardiovascular Imaging|May 22, 2014
Response to letter regarding article, "Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale analysis of putative high-risk features from the risk of paradoxical embolism database"Benjamin S Wessler, David E Thaler, Robin Ruthazer, et al.
Pageof 18